Bronchogen 20mg

Bronchogen — 20 mg

A short bioregulatory peptide of the sequence Ala-Glu-Asp-Leu (AEDL), from the Khavinson family of bioregulators, studied for its potential affinity with bronchial and pulmonary tissues.

Available in France as a lyophilized powder, 20 mg vial, for research on bronchial epithelium, regulation of gene expression and respiratory tissue renewal.

Product intended exclusively for laboratory research. Not intended for human or animal consumption.

Why Bronchogen is of interest to researchers

Bronchogen AEDL is primarily studied for its potential role in regulating bronchial and lung cells. Current research focuses on its interaction with DNA, its possible influence on certain lung cell markers, and its relevance in models of inflammation, tissue remodeling, and bronchial epithelial renewal.

Its short peptide sequence makes it a highly specific compound, valued in research on bioregulatory peptides , particularly those associated with Professor Khavinson ‘s research . Some publications focus on the potential role of short bioregulatory peptides in regulating gene expression in the bronchial epithelium .